Cargando…
Increased Risk for ESBL-Producing Bacteria from Co-administration of Loperamide and Antimicrobial Drugs for Travelers’ Diarrhea
Antimicrobial drug treatment of travelers’ diarrhea is known to increase the risk for colonization with extended-spectrum β-lactamase-producing Enterobacteriaceae. Among 288 travelers with travelers’ diarrhea, the colonization rate without medications was 21%. For treatment with loperamide only, the...
Autores principales: | Kantele, Anu, Mero, Sointu, Kirveskari, Juha, Lääveri, Tinja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4696706/ https://www.ncbi.nlm.nih.gov/pubmed/26691898 http://dx.doi.org/10.3201/eid2201.151272 |
Ejemplares similares
-
Antimicrobials Increase Travelers' Risk of Colonization by Extended-Spectrum Betalactamase-Producing Enterobacteriaceae
por: Kantele, Anu, et al.
Publicado: (2015) -
Despite Predominance of Uropathogenic/Extraintestinal Pathotypes Among Travel-acquired Extended-spectrum β-Lactamase–producing Escherichia coli, the Most Commonly Associated Clinical Manifestation Is Travelers’ Diarrhea
por: Kantele, Anu, et al.
Publicado: (2020) -
High number of diarrhoeal co-infections in travellers to Benin, West Africa
por: Lääveri, Tinja, et al.
Publicado: (2014) -
Prevalence of diarrhoeal pathogens among children under five years of age with and without diarrhoea in Guinea-Bissau
por: Mero, Sointu, et al.
Publicado: (2021) -
Extended-spectrum beta-lactamase-producing strains among diarrhoeagenic Escherichia coli—prospective traveller study with literature review
por: Kantele, Anu, et al.
Publicado: (2021)